{"rewrite":{"id":"r_746cc951f32e03e52d065dd1","clusterId":"c_e1eb0b7cf260f1e968b52e2f","slug":"fda-approves-wearable-that-tracks-blood-sugar-and-ketones-in-diabetes-patients","model":"deepseek-v4-flash","headline":"FDA Approves Wearable That Tracks Blood Sugar and Ketones in Diabetes Patients","summary":"The U.S. FDA approved the Libre Duo 10 Day, a wearable device from Abbott that continuously monitors both blood sugar and ketone levels in diabetes patients. The device measures both metrics every minute and sends alerts when values hit set thresholds. Abbott plans a U.S. launch during 2026.","whyItMatters":"Continuous ketone tracking gives type 1 diabetes patients a way to catch dangerous ketoacidosis early, a capability single-point measurements could not offer.","webCardHtml":"\u003cp\u003eThe device measures glucose and ketones in the fluid just beneath the skin every minute, day and night, and transmits the data wirelessly to a smartphone. It is intended for patients aged 2 and older and can be worn for up to 10 days.\u003c/p\u003e\u003cp\u003eAbbott says it is working with major insulin pump manufacturers to enable integration with automated insulin delivery systems in the future. The company plans to launch the device in the United States during 2026.\u003c/p\u003e","blueskyPost":"The FDA cleared Abbott's Libre Duo 10 Day, a wearable that tracks both blood sugar and ketones continuously. It alerts patients when ketone levels climb, a step toward catching diabetic ketoacidosis early.","twitterPost":"FDA clears Abbott's Libre Duo 10 Day, a wearable that monitors blood sugar and ketones every minute and alerts patients when ketone levels rise. U.S. launch planned for 2026.","threadsPost":null,"newsletterBlurb":"The FDA approved Abbott's Libre Duo 10 Day, a wearable that continuously measures blood sugar and ketone levels in diabetes patients. It alerts users when ketone levels rise, addressing a gap in monitoring diabetic ketoacidosis. Abbott plans a U.S. launch during 2026.","attributionJson":"[{\"source\":\"GIGAZINE\",\"url\":\"https://gigazine.net/news/20260826-fda-authorizes-wearable-monitor-ketone-glucose/\",\"title\":\"FDA Approves First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar in Diabetes Patients\"}]","lintFlagsJson":null,"lintHits":0,"costUsd":0,"inputTokens":4719,"outputTokens":486,"status":"published","repairAttempts":0,"nextRepairAt":null,"factsAttemptedAt":1788010430,"createdAt":"2026-08-29T13:29:05.000Z","publishedAt":"2026-08-29T13:31:44.000Z","updatedAt":"2026-08-29T13:29:05.000Z"},"cluster":{"id":"c_e1eb0b7cf260f1e968b52e2f","canonicalTitle":"糖尿病患者のケトン体レベルと血糖値の両方を継続的にモニタリングする初のウェアラブルデバイスをFDAが承認","representativeArticleId":"a_4e4d832eb68002edca0dc8b5","sourceCount":1,"writtenSourceCount":1,"writeAttempts":0,"isSolo":true,"entitiesJson":"{\"anime_titles\":[],\"manga_titles\":[],\"work_titles\":[\"Libre Duo 10 Day\"],\"studios\":[],\"people\":[],\"type\":\"news\",\"domain\":\"other\",\"is_roundup\":false}","contentType":"news","status":"published","firstSeenAt":"2026-08-26T10:00:00.000Z","lastSeenAt":"2026-08-26T10:00:00.000Z","updatedAt":"2026-08-29T13:31:46.000Z"},"attribution":[{"source":"GIGAZINE","url":"https://gigazine.net/news/20260826-fda-authorizes-wearable-monitor-ketone-glucose/","title":"糖尿病患者のケトン体レベルと血糖値の両方を継続的にモニタリングする初のウェアラブルデバイスをFDAが承認"}],"entities":{"anime_titles":[],"manga_titles":[],"work_titles":["Libre Duo 10 Day"],"studios":[],"people":[],"type":"news","domain":"other","is_roundup":false},"keyFacts":null}